Go Therapeutics, Inc.
Computational platform identifying novel drug targets for solid tumor therapies
- Sector
- Biotech
- Headquarters
- CAMBRIDGE, MA
- Latest Form D
- $5M, Aug 2017
- Total capital
- $5M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $5M
- 1 Form D · last Aug 2017
- 110 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 6
- 25 pending · first 2018
- Rank in peer group#37 of 342
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$5M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 342 peers
Line = medianBiotech · Platform
- Granted patents#37 · top 11%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Thayer L. WhiteResearcherDirectorLinked by 2 patents
- Constantine TheodoropulosExecutive Officer, DirectorNamed in SEC Form D filings
- Gregory L. ChaseDirectorNamed in SEC Form D filings
What it has protected
USPTO · 6 granted of 31- PendingANTI-GLYCO-CD44 Antibodies And Their UsesUSPTOApplication 18548772
- PendingANTI-GLYCO-MUC1 Antibodies And Their UsesUSPTOApplication 19068368
- PendingAnti-glyco-cmet Antibodies And Their UsesUSPTOApplication 18688435
Show all 31 patent records
- ANTI-GLYCO-CD44 Antibodies And Their UsesOct 23, 2025 · Application 18548772Pending
- ANTI-GLYCO-MUC1 Antibodies And Their UsesOct 2, 2025 · Application 19068368Pending
- Anti-glyco-cmet Antibodies And Their UsesMay 1, 2025 · Application 18688435Pending
- ANTI-GLYCO-MUC1 Antibodies And Their UsesApr 8, 2025 · US 12,269,892Granted
- ANTI-GLYCO-MUC4 Antibodies And Their UsesMar 27, 2025 · Application 18294677Pending
- ANTI-GLYCO-MUC1 Antibodies And Their UsesMar 6, 2025 · Application 18767099Pending
- ANTI-GLYCO-LAMP1 Antibodies And Their UsesFeb 27, 2025 · Application 18688464Pending
- ANTI-GLYCO-MUC1 Antibodies And Their UsesAug 20, 2024 · US 12,065,504Granted
- CORE3-MUC1 Binding Polypeptides And Uses ThereofJan 2, 2024 · US 11,860,165Granted
- ANTI-GLYCO-CD44 Antibodies And Their UsesApr 27, 2023 · Application 17909045Pending
- ANTI-GLYCO-MUC1 Antibodies And Their UsesNov 2, 2021 · US 11,161,911Granted
- TN-MUC4 Binding Polypeptides And Uses ThereofJul 20, 2021 · US 11,067,578Granted
- TN-MUC4 Binding Polypeptides And Uses ThereofNov 27, 2018 · US 10,139,414Granted
- Methods Of Identifying Glycopeptides Recognized By Disease-associated Auto-antibodiesMar 24, 2016 · Application 14814328Pending
- ANTI-GLYCO-MUC4 Antibodies And Their UsesApplication 63270642Pending
- ANTI-GLYCO-MUC4 Antibodies And Their UsesApplication 63241837Pending
- ANTI-GLYCO-LAMP1 Antibodies And Their UsesApplication 63240773Pending
- Anti-glyco-cmet Antibodies And Their UsesApplication 63240761Pending
- ANTI-GLYCO-MUC4 Antibodies And Their UsesApplication 63229839Pending
- ANTI-GLYCO-CD44 Antibodies And Their UsesApplication 63223698Pending
- ANTI-GLYCO-CD44 Antibodies And Their UsesApplication 63270641Pending
- ANTI-GLYCO-CD44 Antibodies And Their UsesApplication 63157601Pending
- ANTI-GLYCO-CD44 Antibodies And Their UsesApplication PCTUS2021021211Pending
- ANTI-GLYCO-CD44 Antibodies And Their UsesApplication PCTUS2022018863Pending
- ANTI-GLYCO-CD44 Antibodies And Their UsesApplication 62986083Pending
- ANTI-GLYCO-MUC1 Antibodies And Their UsesApplication PCTUS2019039883Pending
- ANTI-GLYCO-MUC4 Antibodies And Their UsesApplication PCTUS2022039390Pending
- ANTI-GLYCO-LAMP1 Antibodies And Their UsesApplication PCTUS2022042457Pending
- ANTI-GLYCO-MUC1 Antibodies And Their UsesApplication PCTUS2017058036Pending
- Anti-glyco-cmet Antibodies And Their UsesApplication PCTUS2022042455Pending
- Antibody Fusion Proteins Comprising ANTI-GLYCO-MUC4 Antibodies And Mic Protein A1-A2 Domains, And Their UsesApplication PCTUS2024014584Pending
Related companies, and why
- Arbor Assets IncSimilar federal contract value in Biotech · null in contracts
- Prothena Corp plcSimilar federal contract value in Biotech · null in contracts
- EXAVIR THERAPEUTICS INC.Similar federal contract value in Biotech · null in contracts
- OPAL THERAPEUTICS INCSimilar federal contract value in Biotech · null in contracts
- GlycomineSimilar federal contract value in Biotech · null in contracts
- Glyscend IncSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .